Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis
about
Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/ConneThe synthetic peptide P111-136 derived from the C-terminal domain of heparin affin regulatory peptide inhibits tumour growth of prostate cancer PC-3 cells.A Pleiotrophin C-terminus peptide induces anti-cancer effects through RPTPβ/ζA therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165Effects of pleiotrophin overexpression on mouse skeletal muscles in normal loading and in actual and simulated microgravity.Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2.ABT-510 induces tumor cell apoptosis and inhibits ovarian tumor growth in an orthotopic, syngeneic model of epithelial ovarian cancer.Loss of receptor protein tyrosine phosphatase β/ζ (RPTPβ/ζ) promotes prostate cancer metastasisExtracellular angiogenic growth factor interactions: an angiogenesis interactome survey.Interplay between αvβ3 integrin and nucleolin regulates human endothelial and glioma cell migration.Enhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALK.Heparin-binding protein pleiotrophin: an important player in the angiogenic process.Zinc-ion binding and cytokine activity regulation pathways predicts outcome in relapsing-remitting multiple sclerosis.Pleiotrophin exerts its migration and invasion effect through the neuropilin-1 pathwayReceptor protein tyrosine phosphatase beta/zeta is a functional binding partner for vascular endothelial growth factorThrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action.Modulation of VEGF receptor 2 signaling by protein phosphatases.Concentration- and time-dependent effects of enoxaparin on human adenocarcinomic epithelial cell line A549 proliferation in vitro.Specific VEGF sequestering to biomaterials: influence of serum stability.Heparin affin regulatory peptide modulates the endogenous anticoagulant activity of heparin and heparan sulphate mimetics.Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease.A minimally invasive endovascular rabbit model for experimental induction of progressive myocardial hypertrophy.Pleiotrophin is a potential colorectal cancer prognostic factor that promotes VEGF expression and induces angiogenesis in colorectal cancer.Cutting to the Chase: How Matrix Metalloproteinase-2 Activity Controls Breast-Cancer-to-Bone Metastasis.Isolation and differential transcriptome of vascular smooth muscle cells and mid-capillary pericytes from the rat brain
P2860
Q33301092-49550254-DC17-4C41-84C6-510FE3579988Q33915644-F7F45292-6E3C-44FF-BCFD-B42FB28098DCQ34114284-06A0289D-80B8-4D8C-914F-461C5464F57EQ34245063-FAF23A91-0C1B-4443-BAAA-1E6B91E4CC94Q34981338-9CC9FBA3-9EFE-4564-AAF0-218347822B87Q35902676-41AE0505-D959-4968-8031-5118ADB6A1CDQ36060215-2517FC6F-4631-464A-91ED-C099B8913B8BQ36418808-27222F8F-391A-4A71-81F2-2F6DB94B27E1Q36489766-4BB2DD1C-19B1-4C7A-8339-8D0B4CB7B200Q36508636-EB8FD029-8319-4F59-BA30-DF09D912EDFDQ37073265-C150129E-EEAB-4671-9417-E5F812E8E8ECQ37228534-A9C9B286-0205-422C-BBE2-6F4612D22EC4Q38301931-9044DB63-419C-4B57-96EE-CC2EC5A0A8F7Q38832365-9C5E471A-832B-4F81-A36A-ED841F145AE3Q38913862-3B7DDA9C-92CD-44F2-BBF5-A2CB4567DAE3Q38974266-08702BCB-2356-4518-B1CE-460153608170Q39020269-684BCFCE-CBDE-45BB-B09D-DA68F2A61154Q39476635-8F5E6D41-70E9-42F1-8E93-E939F31EF90CQ42049840-A25F8502-1B0D-444B-8793-290A79C1CD4DQ47658657-5B3EDE39-BD08-4A9A-8ECE-7F525F601168Q48227262-088E0F7C-ED46-4E3C-9FC2-64301E43B71BQ51687887-38229263-F8C5-4FD0-BDAC-0926DF85CB01Q51848175-41A9952E-5B6C-4B38-A607-42274699B4EFQ55515529-1058B921-87A1-45A5-AB35-51EF084E55A3Q58774734-F1F4D80F-33BA-4A93-A3D0-E5C59EBBE4DA
P2860
Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Heparin affin regulatory pepti ...... bits VEGF-induced angiogenesis
@ast
Heparin affin regulatory pepti ...... bits VEGF-induced angiogenesis
@en
Heparin affin regulatory pepti ...... bits VEGF-induced angiogenesis
@en-gb
Heparin affin regulatory pepti ...... bits VEGF-induced angiogenesis
@nl
type
label
Heparin affin regulatory pepti ...... bits VEGF-induced angiogenesis
@ast
Heparin affin regulatory pepti ...... bits VEGF-induced angiogenesis
@en
Heparin affin regulatory pepti ...... bits VEGF-induced angiogenesis
@en-gb
Heparin affin regulatory pepti ...... bits VEGF-induced angiogenesis
@nl
prefLabel
Heparin affin regulatory pepti ...... bits VEGF-induced angiogenesis
@ast
Heparin affin regulatory pepti ...... bits VEGF-induced angiogenesis
@en
Heparin affin regulatory pepti ...... bits VEGF-induced angiogenesis
@en-gb
Heparin affin regulatory pepti ...... bits VEGF-induced angiogenesis
@nl
P2093
P356
P1433
P1476
Heparin affin regulatory pepti ...... bits VEGF-induced angiogenesis
@en
P2093
Denis Barritault
Evangelia Papadimitriou
Isabelle Bernard-Pierrot
Jean Delbé
Jean Plouet
José Courty
Mélanie Héroult
Panagiotis Katsoris
Yamina Hamma-Kourbali
P2888
P304
P356
10.1038/SJ.ONC.1206879
P407
P577
2004-03-04T00:00:00Z
P5875
P6179
1044681508